Literature DB >> 1390017

Improving communication with cancer patients.

L A Siminoff1.   

Abstract

Although much more information is being disclosed to cancer patients than in the past, there is still considerable disagreement about how much information should be conveyed. This paper reviews the basic elements of informed consent, examines some of the major barriers to effective communication, and suggests ways in which physicians can enhance communication with their cancer patients. Physicians are urged to evaluate patients in terms of their coping and information-seeking styles and to keep in mind that most patients want information. In fact, studies show that giving patients adequate information usually impacts positively on their psychological and physical well-being.

Entities:  

Mesh:

Year:  1992        PMID: 1390017

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  10 in total

Review 1.  The promise of empirical research in the study of informed consent theory and practice.

Authors:  Laura A Siminoff; Marie Caputo; Christopher Burant
Journal:  HEC Forum       Date:  2004-03

2.  The good news about giving bad news to patients.

Authors:  Neil J Farber; Susan Y Urban; Virginia U Collier; Joan Weiner; Ronald G Polite; Elizabeth B Davis; E Gil Boyer
Journal:  J Gen Intern Med       Date:  2002-12       Impact factor: 5.128

3.  The patient's perspective: a qualitative study of acute myeloid leukaemia patients' need for information and their information-seeking behaviour.

Authors:  Lone S Friis; Beth Elverdam; Kai G Schmidt
Journal:  Support Care Cancer       Date:  2003-01-16       Impact factor: 3.603

4.  Doctor-patient communication patterns in breast cancer adjuvant therapy discussions.

Authors:  Laura A. Siminoff; Peter Ravdin; Natalie Colabianchi; Christina M. Saunders Sturm
Journal:  Health Expect       Date:  2000-03       Impact factor: 3.377

5.  Unanticipated toxicities from anticancer therapies: survivors' perspectives.

Authors:  Mona Gandhi; Karen Oishi; Beth Zubal; Mario E Lacouture
Journal:  Support Care Cancer       Date:  2009-12-03       Impact factor: 3.603

6.  Measuring decision quality: psychometric evaluation of a new instrument for breast cancer chemotherapy.

Authors:  Clara N Lee; Matthew H Wetschler; Yuchiao Chang; Jeffrey K Belkora; Beverly Moy; Ann Partridge; Karen R Sepucha
Journal:  BMC Med Inform Decis Mak       Date:  2014-08-20       Impact factor: 2.796

7.  Xerosis and pruritus as major EGFRI-associated adverse events.

Authors:  Julia M K Clabbers; Christine B Boers-Doets; Hans Gelderblom; Theo Stijnen; Mario E Lacouture; Koos J M van der Hoeven; Adrian A Kaptein
Journal:  Support Care Cancer       Date:  2015-06-27       Impact factor: 3.603

8.  Patient-physician communication concerning participation in cancer chemotherapy trials.

Authors:  J B Sørensen; P Rossel; S Holm
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

9.  An effective multisource informed consent procedure for research and clinical practice: an observational study of patient understanding and awareness of their roles as research stakeholders in a cancer biobank.

Authors:  Silvia Cervo; Jane Rovina; Renato Talamini; Tiziana Perin; Vincenzo Canzonieri; Paolo De Paoli; Agostino Steffan
Journal:  BMC Med Ethics       Date:  2013-07-30       Impact factor: 2.652

10.  Decision Making in the PICU: An Examination of Factors Influencing Participation Decisions in Phase III Randomized Clinical Trials.

Authors:  Laura E Slosky; Marilyn Stern; Natasha L Burke; Laura A Siminoff
Journal:  Int J Pediatr       Date:  2014-08-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.